SCHEMBL4331374

SCHEMBL4331374

CC1CC(c2ccccc2)(c2cc(OCc3ccc4ccccc4n3)ccc2-c2nc(Cl)c[nH]2)C1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 20/20 0.65
ALOX5 P09917 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13750393 0.83 ALOX5AP (0.62) ALOX5APALOX5
SCHEMBL3582653 0.82 ALOX5AP (0.69) ALOX5APALOX5
SCHEMBL4323551 0.81 ALOX5AP (0.60) ALOX5AP
SCHEMBL4320159 0.81 ALOX5AP (0.62) ALOX5APALOX5
SCHEMBL4235296 0.80 ALOX5AP (0.78) ALOX5APALOX5
SCHEMBL13757932 0.79 ALOX5AP (0.71) ALOX5APALOX5
SCHEMBL4315839 0.78 ALOX5AP (0.85) ALOX5AP
SCHEMBL4236116 0.78 ALOX5AP (1.00) ALOX5AP
SCHEMBL4317892 0.78 ALOX5AP (0.57) ALOX5AP
SCHEMBL4327149 0.76 ALOX5AP (0.56) ALOX5APALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use MERCK SHARP & DOHME CORP. 2009-08-06 US disclosed
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use MERCK SHARP & DOHME CORP. 2009-08-06 US disclosed
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use MERCK SHARP & DOHME CORP. 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197883-A1 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use ALOX5, LTC4S, ALOX15B ALOX5AP 16/4885ALOX5 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.